3/29/2024 | 30049049 | IRINOTEL (IRINOTECAN) HCL INJ. 100MG/5MLBATCH NO. 87230465BP, MFG.DT. 11/23, EXP.DT. 10/25 | FRESENIUS KABI ONCOLOGY LIMITED | 150 | NOS | 1530.79 | UNITED ARAB EMIRATES | DELHI AIR |
3/29/2024 | 30049049 | IRINOTEL (IRINOTECAN) HCL INJ. 100MG/5MLBATCH NO. 87240025AF, MFG.DT. 01/24, EXP.DT. 12/25 | FRESENIUS KABI ONCOLOGY LIMITED | 600 | NOS | 6501.26 | UNITED ARAB EMIRATES | DELHI AIR |
3/29/2024 | 30049049 | IRINOTEL (IRINOTECAN) HCL INJ. 100MG/5MLBATCH NO. 87240025AF, MFG.DT. 01/24, EXP.DT. 12/25 | FRESENIUS KABI ONCOLOGY LIMITED | 250 | NOS | 2685.96 | UNITED ARAB EMIRATES | DELHI AIR |
3/28/2024 | 29349990 | IRINOTECAN HYDROCHLORIDE USP (TAX INV# SI3623228318 DT:28.02.2024) | HETERO LABS LIMITED | 6.6 | KGS | 142047.45 | UNITED ARAB EMIRATES | SAHAR AIR |
3/27/2024 | 30049099 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE PRODUCTS : IRINOTECAN IRITERO 100MG/5ML INJ,PACK-VIAL | DOSHI MEDICARE PRIVATE LIMITED | 5 | VLS | 45.36 | UNITED KINGDOM | SAHAR AIR |
3/21/2024 | 30049049 | PHA.DRU & MEDI, IRINOTECAN HCL INJ,20MG/ML,2ML(ACCORD EACH ML CONTAINS : IRINOTECAN HYDROCHLORIDE TRIHYDRATE | INTAS PHARMACEUTICALS LIMITED | 2699 | VLS | 4683.55 | UNITED KINGDOM | SAHAR AIR |
2/15/2024 | 30049049 | PHARMA DRUGS & MEDI IRINOTECAN 20MG/ML25ML(ACCORD-UK AS PER INVOICEVLS | INTAS PHARMACEUTICALS LIMITED | 1464 | VLS | 17849.52 | UNITED KINGDOM | MUNDRA SEA |
1/25/2024 | 30049049 | PHARMA DRUGS & MEDI IRINOTECAN HCL INJ,20MG/ML,5ML(ACCORD AS PER INVOICEVLS | INTAS PHARMACEUTICALS LIMITED | 2768 | VLS | 10316.75 | UNITED KINGDOM | MUNDRA SEA |
1/25/2024 | 30049049 | PHARMA DRUGS & MEDI IRINOTECAN HCL INJ,20MG/ML,5ML(ACCORD AS PER INVOICEVLS | INTAS PHARMACEUTICALS LIMITED | 2768 | VLS | 10316.75 | UNITED KINGDOM | MUNDRA SEA |
1/25/2024 | 30049049 | PHARMA DRUGS & MEDI IRINOTECAN 20MG/ML,5ML(ACCORD-UK AS PER INVOICEVLS | INTAS PHARMACEUTICALS LIMITED | 2677 | VLS | 8609.5 | UNITED KINGDOM | MUNDRA SEA |